These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Characteristics of [3H] propyl beta-carboline-3-carboxylate binding to benzodiazepine receptors in human brain. Chiu P, Chiu S, Mishra RK. Res Commun Chem Pathol Pharmacol; 1984 May; 44(2):199-213. PubMed ID: 6330818 [Abstract] [Full Text] [Related]
7. Functional modulation of cerebral gamma-aminobutyric acidA receptor/benzodiazepine receptor/chloride ion channel complex with ethyl beta-carboline-3-carboxylate: presence of independent binding site for ethyl beta-carboline-3-carboxylate. Taguchi J, Kuriyama K. J Pharmacol Exp Ther; 1990 May; 253(2):558-66. PubMed ID: 2159999 [Abstract] [Full Text] [Related]
8. Brain benzodiazepine receptors increase after chronic ethyl-beta-carboline-3-carboxylate. Concas A, Salis M, Biggio G. Life Sci; 1983 Mar 14; 32(11):1175-82. PubMed ID: 6300577 [Abstract] [Full Text] [Related]
9. Photoaffinity labelling of the benzodiazepine receptor cannot be used to predict ligand efficacy. Brown CL, Martin IL. Neurosci Lett; 1983 Jan 31; 35(1):37-40. PubMed ID: 6302605 [Abstract] [Full Text] [Related]
11. Heterogeneity of [3H]ethyl beta-carboline-3-carboxylate binding sites and [3H]gamma-aminobutyric acid binding sites. Tao PL, Chang LR, Lee HK. Chin J Physiol; 1986 Feb 31; 29(1):13-29. PubMed ID: 3019614 [Abstract] [Full Text] [Related]
12. Binding of [3H]DMCM, a convulsive benzodiazepine ligand, to rat brain membranes: preliminary studies. Braestrup C, Nielsen M, Honoré T. J Neurochem; 1983 Aug 31; 41(2):454-65. PubMed ID: 6308161 [Abstract] [Full Text] [Related]
13. The interaction of substituted benzamides with brain benzodiazepine binding sites in vitro. Horton RW, Lowther S, Chivers J, Jenner P, Marsden CD, Testa B. Br J Pharmacol; 1988 Aug 31; 94(4):1234-40. PubMed ID: 2850059 [Abstract] [Full Text] [Related]
14. Properties of [3H]flunitrazepam binding to different benzodiazepine binding proteins. Sieghart W, Mayer A, Drexler G. Eur J Pharmacol; 1983 Apr 08; 88(4):291-9. PubMed ID: 6134627 [Abstract] [Full Text] [Related]
15. Central-type benzodiazepine binding sites in rat pituitary gland are of the BZ1 subtype. Anderson RA, Mitchell R. Neuropharmacology; 1984 Nov 08; 23(11):1331-4. PubMed ID: 6098848 [Abstract] [Full Text] [Related]
16. Studies on [3H]diazepam and [3H]ethyl-beta-carboline carboxylate binding to rat brain in vivo. I. Regional variations in displacement. Minchin MC, Nutt DJ. J Neurochem; 1983 Dec 08; 41(6):1507-12. PubMed ID: 6417271 [Abstract] [Full Text] [Related]
17. Stereoisomeric tetrahydro-beta-carbolines differ in their interaction with rat brain benzodiazepine receptors. Locock AR, Baker GB, Micetich RG, Coutts RT. Prog Neuropsychopharmacol Biol Psychiatry; 1983 Dec 08; 7(4-6):808-12. PubMed ID: 6320306 [Abstract] [Full Text] [Related]
18. Allosteric modulation of flunitrazepam binding to rat brain benzodiazepine receptors by methyl beta-carboline-3-carboxylate. Chiu TH, Rosenberg HC. J Neurochem; 1985 Jan 08; 44(1):306-9. PubMed ID: 2981101 [Abstract] [Full Text] [Related]
19. Effect of taurine on a benzodiazepine-GABA-chloride ionophore receptor complex in rat brain membranes. Iwata H, Nakayama K, Matsuda T, Baba A. Neurochem Res; 1984 Apr 08; 9(4):535-44. PubMed ID: 6087177 [Abstract] [Full Text] [Related]